Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Maribor

29 clinical trials in Maribor, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Maribor at a glance
29
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

29 trials in Maribor

Open in trial search
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Investigational
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Azd8205
  • Sponsor:AstraZeneca AB
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Sponsor:Takeda Development Center Americas Inc.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Noradrenaline Tartrate
  • Sponsor:Amsterdam UMC Stichting
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Pfizer Inc.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Epoetin Alfa
  • Sponsor:University College Dublin
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Amgen Inc.

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Maribor

What the registry says about research in the country

01 Neurological Disorders

Research focusing on breakthrough treatments for Multiple Sclerosis and neurodegenerative conditions, including evaluations of novel therapies like remibrutinib and ocrelizumab. Studies are examining treatment effectiveness for patients with various forms of MS.

  • Relapsing Multiple Sclerosis (RMS)
  • Early Alzheimer's Disease
  • Refractory Focal Onset Epilepsy

Innovative trials exploring cognitive improvement and disease progression reduction.

02 Autoimmune Conditions

Comprehensive studies evaluating treatments for Sjögren's Syndrome and other autoimmune disorders, with particular focus on systemic manifestations and long-term safety profiles.

  • IgA Nephropathy
  • Hidradenitis Suppurativa
  • Crohn's Disease

Trials aimed at developing targeted therapies for moderate to severe disease manifestations.

03 Oncology Research

Advanced clinical investigations in Non-Small Cell Lung Cancer and gynecological cancers, evaluating novel combination therapies and maintenance treatments.

  • Advanced Endometrial Cancer
  • Multiple Myeloma
  • PD-L1 High NSCLC

Focus on immunotherapy combinations and targeted treatment approaches.

04 Critical Care Medicine

Studies addressing acute medical conditions including cardiogenic shock and severe respiratory infections, with emphasis on improving patient outcomes.

  • Traumatic Injury
  • Community-Acquired Pneumonia
  • Acute Myocardial Infarction

Research aimed at reducing mortality and improving treatment protocols in critical care settings.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).